Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

260 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment.
Sakuraba A, Motoya S, Watanabe K, Nishishita M, Kanke K, Matsui T, Suzuki Y, Oshima T, Kunisaki R, Matsumoto T, Hanai H, Fukunaga K, Yoshimura N, Chiba T, Funakoshi S, Aoyama N, Andoh A, Nakase H, Mizuta Y, Suzuki R, Akamatsu T, Iizuka M, Ashida T, Hibi T. Sakuraba A, et al. Among authors: funakoshi s. Am J Gastroenterol. 2009 Dec;104(12):2990-5. doi: 10.1038/ajg.2009.453. Epub 2009 Sep 1. Am J Gastroenterol. 2009. PMID: 19724269 Clinical Trial.
Role of daunorubicin in the induction therapy for adult acute myeloid leukemia.
Usui N, Dobashi N, Kobayashi T, Yano S, Maki N, Asai O, Saito T, Yamaguchi Y, Watanabe H, Kato A, Ogihara A, Katori M, Nagamine M, Takei Y, Yamazaki H, Funakoshi S, Tajima N, Ogawa M, Kuraishi Y. Usui N, et al. Among authors: funakoshi s. J Clin Oncol. 1998 Jun;16(6):2086-92. doi: 10.1200/JCO.1998.16.6.2086. J Clin Oncol. 1998. PMID: 9626208 Clinical Trial.
Measurement of colonic mucosal concentrations of 5-aminosalicylic acid is useful for estimating its therapeutic efficacy in distal ulcerative colitis: comparison of orally administered mesalamine and sulfasalazine.
Naganuma M, Iwao Y, Ogata H, Inoue N, Funakoshi S, Yamamoto S, Nakamura Y, Ishii H, Hibi T. Naganuma M, et al. Among authors: funakoshi s. Inflamm Bowel Dis. 2001 Aug;7(3):221-5. doi: 10.1097/00054725-200108000-00007. Inflamm Bowel Dis. 2001. PMID: 11515848
Anti-high mobility group box 1 and box 2 non-histone chromosomal proteins (HMGB1/HMGB2) antibodies and anti-Saccharomyces cerevisiae antibodies (ASCA): accuracy in differentially diagnosing UC and CD and correlation with inflammatory bowel disease phenotype.
Takaishi H, Kanai T, Nakazawa A, Sugata F, Nikai A, Yoshizawa S, Hamamoto Y, Funakoshi S, Yajima T, Iwao Y, Takemura M, Ozaki S, Hibi T. Takaishi H, et al. Among authors: funakoshi s. J Gastroenterol. 2012 Sep;47(9):969-77. doi: 10.1007/s00535-012-0566-3. Epub 2012 May 30. J Gastroenterol. 2012. PMID: 22644337
A Phase II Study of Regorafenib With a Lower Starting Dose in Patients With Metastatic Colorectal Cancer: Exposure-Toxicity Analysis of Unbound Regorafenib and Its Active Metabolites (RESET Trial).
Suzuki T, Sukawa Y, Imamura CK, Masuishi T, Satake H, Kumekawa Y, Funakoshi S, Kotaka M, Horie Y, Kawai S, Okuda H, Terazawa T, Kondoh C, Kato K, Yoshimura K, Ishikawa H, Hamamoto Y, Boku N, Takaishi H, Kanai T. Suzuki T, et al. Among authors: funakoshi s. Clin Colorectal Cancer. 2020 Mar;19(1):13-21.e3. doi: 10.1016/j.clcc.2019.10.004. Epub 2019 Oct 23. Clin Colorectal Cancer. 2020. PMID: 31732439 Clinical Trial.
260 results